MGMT and neoplasm: None of the other clinicopathological parameters analyzed, including age, lymph node metastasis, primary tumor location, tumor grade, tumor size, TNM stage, progesterone receptor expression, Her-2 or Ki-67, were significantly associated with MGMT expression (p >0.05, Table 1).